ConjuChem retains Bloom Burton Co. – Stockhouse
2010 March 11
… The creation of new drugs for the treatment significantly improved performance than the original peptide. The company has two major development projects: a computer-DAC (TM): Exendin – 4, GLP – 1 of the agonist phase-II diabetes two …
Read More
